FPRX - Five Prime Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
17,941
14,874
49,868
39,508
30,691
Operating Expense
143,596
156,812
196,023
190,910
129,903
Operating Income
-125,655
-141,938
-146,155
-151,402
-99,212
Net Non Operating Interest Income Expense
3,724
4,740
5,792
2,978
2,467
Other Income Expense
-
-4
-84
-94
-
Pretax Income
-121,933
-137,202
-140,447
-148,518
-96,745
Tax Provision
0
0
0
1,704
-31,048
Net Income Common Stockholders
-121,933
-137,202
-140,447
-150,222
-65,697
Diluted NI Available to Com Stockholders
-121,933
-137,202
-140,447
-150,222
-65,697
Basic EPS
-
-0.0039
-0.0041
-0.0054
-0.0024
Diluted EPS
-
-0.0039
-0.0041
-0.0054
-0.0024
Basic Average Shares
-
34,970
33,976
27,945
26,955
Diluted Average Shares
-
34,970
33,976
27,945
26,955
Total Operating Income as Reported
-125,655
-141,938
-146,155
-151,402
-99,212
Total Expenses
143,596
156,812
196,023
190,910
129,903
Net Income from Continuing & Discontinued Operation
-121,933
-137,202
-140,447
-150,222
-65,697
Normalized Income
-121,933
-137,202
-140,447
-150,222
-65,697
Interest Income
3,724
4,740
5,792
2,978
2,467
Net Interest Income
3,724
4,740
5,792
2,978
2,467
EBIT
-125,655
-141,938
-146,155
-151,402
-99,212
EBITDA
-120,381
-
-
-
-
Reconciled Depreciation
5,274
5,313
5,020
2,513
1,742
Net Income from Continuing Operation Net Minority Interest
-121,933
-137,202
-140,447
-150,222
-65,697
Total Unusual Items Excluding Goodwill
-
-
-
-94
0
Total Unusual Items
-
-
-
-94
0
Normalized EBITDA
-120,381
-136,625
-141,135
-148,889
-97,470
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0